Articles tagged with Autoimmune Disorders
Babraham Institute group leader Dr Rahul Roychoudhuri has been selected for the £200,000 Lister Institute Research Prize Fellowship to support his research on immune system regulation and suppression. His goal is to better understand how gene regulators affect T cells and potentially treat autoimmune diseases.
Researchers have identified a key feature of mevalonate kinase deficiency (MKD), a rare genetic condition, by finding untethered proteins in the cells of children with the disease. This discovery could help fast-track diagnosis and provide new insights into the disease process.
A University of Maryland expert has diagnosed Francisco Goya with a rare autoimmune syndrome or syphilis after suffering from severe illness and hearing loss in 1793. She notes that Goya's condition would have been treatable today.
Scientists have discovered clues into how a destructive autoimmune disease works using a unique microscope capable of illuminating living cell structures. They were able to see clusters of antibodies atop astrocytes, the brain cell target of the autoimmune response in neuromyelitis optica.
Researchers have explored the potential of this novel therapeutic approach, demonstrating promising pre-clinical data with over 40 scientific papers. Vectored-antibody delivery using rAAV offers advantages in treatment of various chronic and infectious diseases.
Researchers at Osaka University have found that the breakdown of SEMA4D protein causes inflammation and disease in AAV patients. The study suggests that SEMA4D could be used as a new clinical marker to improve diagnosis accuracy.
Researchers at the University of Basel have created a treatment approach using customized synthetic glycopolymers that act as molecular sponges to neutralize disease-causing antibodies. This innovative method has potential applications for treating other antibody-mediated autoimmune diseases.
The U.S. National Institutes of Health now requires funding applicants to consider sex as a variable in proposed research, aiming to address disparities in health outcomes. However, some scientists express concerns about the policy's potential impact on research costs and data quality.
A study by Brigham and Women's Hospital investigators found that 55 out of 270 genetic loci associated with seven autoimmune diseases could be mapped back to causal genes using eQTLs in immune cells. However, this only accounts for a small fraction of the genetic loci examined.
Researchers have made significant progress treating anti-NMDA receptor encephalitis with a new regimen, including patients who previously did not respond. The treatment, which includes bortezomib, has shown to quickly improve clinical symptoms and reduce antibodies responsible for the disease.
Researchers at Osaka University discovered a molecular mechanism underlying some autoimmune diseases. Satb1 regulates the development of regulatory T cells (Treg cells), which are essential for controlling hyperactive immune systems.
A landmark study published in eLife reveals that trisomy 21 consistently activates the interferon response, leading to increased interferon-stimulated genes and lower protein synthesis. This discovery has significant implications for understanding Down syndrome and its characteristic features.
Resolvins and maresins, naturally produced omega-3 fatty acid molecules, regulate subsets of white blood cells that play a central role in inflammation. The findings suggest these molecules may be useful for treating chronic inflammatory and autoimmune diseases.
Researchers at the Gladstone Institutes have developed a new method to consistently activate mesenchymal stromal cells to produce anti-inflammatory proteins, enhancing their immune-suppressing effects. This breakthrough could lead to improved treatments for inflammatory bowel disease and organ transplant rejection.
A recent study of 70,265 Swedish girls and women found that HPV vaccination did not increase the risk of developing another autoimmune disease. Vaccination was associated with a slightly reduced risk compared to not being vaccinated.
Scientists develop CAR-fused T cells that recognize abnormal B cells in autoimmune diseases like pemphigus vulgaris, reducing symptoms and promoting long-lasting effects.
Scientists at Hokkaido University found that ARL3 facilitates STAT3 transport into the nucleus, regulating gene expression and cell proliferation. This discovery offers promising candidates for novel therapies targeting STAT3-related diseases.
Scientists at the University of Pennsylvania have developed a new therapy that selectively targets antibody-producing cells causing autoimmune disease, without harming the rest of the immune system. The treatment uses engineered T cells with an artificial receptor to bind to and destroy harmful B cells producing antibodies.
A study found that sirolimus successfully resolved autoimmune conditions in children with ALPS without adverse side effects. The treatment improved blood cell counts and quality of life for patients, making it a potential early therapy option.
A team of researchers found that sialic acid reduces antibody-induced cell killing, offering potential treatment for autoimmune diseases. Antibodies with this sugar structure are detectable more frequently in healthy individuals than those with autoimmune diseases.
Pregnant women with rare autoimmune diseases face higher risks of hypertensive disorders, bleeding complications, and preterm births. Infants born to these mothers are also at increased risk of life-threatening conditions, emphasizing the importance of close prenatal care.
Scientists solve the mystery of polar bear Knut's encephalitis, a rare autoimmune disease previously known only in humans. The discovery provides new insights into the possible prevalence of autoimmunity in humans and other mammals.
Research finds gut microbes produce a molecule mimicking retinal protein, activating T cells responsible for autoimmune uveitis. The study offers a novel mechanism explaining how tissue-specific autoimmune diseases can arise from responses to gut microbes at a distal site in the body.
A new Penn study found that hydrogen sulfide regulates Treg cells by modifying a transcription factor called NFYB, leading to improved function and development of these regulatory cells. The study suggests potential therapeutic interventions for autoimmune diseases, cancer, and hypertension.
Researchers at Karolinska Institutet have discovered a new link between male infertility and autoimmune prostatic inflammation. The study found that the immune system reacts to a protein called transglutaminase 4 in men with autoimmune polyendocrine syndrome type 1, leading to reduced fertility.
Researchers found that mutations in one copy of the AIRE gene can cause symptoms of a rare autoimmune disorder, paving the way for specific diagnostic and treatment strategies. Dominant AIRE mutations are also more common than previously thought, occurring in at least 1 in 1,000 individuals.
Researchers have found that narcolepsy bears the hallmarks of a classic autoimmune disorder, with a particular autoantibody process triggering the loss of orexin neurons. This discovery opens up new avenues for diagnosis and treatment, potentially leading to a better understanding of the disease.
A blood test can help doctors predict which patients with an autoimmune disease are at risk of relapse, potentially preventing kidney failure. Researchers found that autoantibody increases were linked to an 11-fold increased risk of relapse in patients with kidney involvement.
The article highlights the role of pattern recognition receptors in regulating immune responses and their potential as novel targets for developing potent new therapies. The JAK/STAT signaling network also plays a crucial role in disease pathogenesis, and targeting these networks may lead to improved treatments for various diseases.
Researchers discovered a paradoxical immune protein that both helps and hinders the immune system response, leading to increased susceptibility to rare bacterial infections and predisposition to autoimmune diseases. The protein ISG15 plays a crucial role in resolving inflammation and preventing autoinflammatory disorders.
A new study suggests that an autoimmune response may contribute to the development of high blood pressure. Using mouse models, researchers found that compounds stimulating hypertension led to the faulty production of modified proteins in dendritic cells, triggering an immune response.
Researchers from the University of Buffalo have discovered new details of how autoantibodies destroy healthy cells in skin, providing insights into autoimmune mechanisms that could help develop and screen treatments for patients suffering from all autoimmune diseases. The study uses atomic force microscopy to analyze cell junctions and...
A study by Penn Medicine researchers found a common genetic link among patients with pemphigus vulgaris, a blistering skin disease. The researchers identified a particular gene, VH1-46, that was used by PV antibodies across all four patients, suggesting common mechanisms for developing the disease.
Researchers found that all-trans retinoid acid enhances a key subset of T cells that promote immune system tolerance. This finding suggests the potential use of Vitamin A to treat autoimmune diseases and protect organ recipients.
Professor Richard Pleass of LSTM has developed a biomimetic called Hexagard, which is approximately 50 fold more effective than current IVIG therapy. The innovative treatment aims to replace IVIG therapy for treating autoimmune diseases in developing countries where it is unaffordable.
A large group of U.S. patients with PSC and primary biliary cirrhosis showed an association between coffee consumption and reduced risk of PSC. The study suggests that PSC differs from primary biliary cirrhosis in terms of lifestyle factors, potentially offering new insights into disease causes and treatment.
A new study found that coffee consumption is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune disease of the bile ducts. Researchers also highlighted the need for better palliative care for terminally ill cirrhotic patients, who often face significant symptoms and challenges.
Researchers have linked 17 genes to juvenile idiopathic arthritis, a significant increase from previous findings of three genes. The study analyzed over 2,800 patient DNA samples and provides new insights into the disease process.
A study published in PLOS ONE found that vitamin D supplements improved gene expression related to cancer, autoimmune diseases, and cardiovascular disease. The researchers observed significant alterations in the activity of 291 genes, with biologic functions associated with 160 biologic pathways linked to these diseases.
Researchers at UCSB have developed inexpensive medical diagnostic tests that can detect a wide range of diseases in under five minutes, using nanometer-scale DNA switches. The new technology has the potential to significantly impact world health by eliminating the lag between testing and treatment.
A new University of Nottingham study will examine the incidence and impact of gluten intolerance in the UK, focusing on coeliac disease and dermatitis herpetiformis. The research aims to improve diagnosis rates and healthcare for affected individuals, with a goal of creating a more accurate estimate of the condition's prevalence.
The study found five significant genetic associations for hypothyroidism, including rs6679677 near PTPN22 and rs925489 near FOXE1, which contribute to understanding the underlying biology of the disease. The results also highlight potential pathways of treatment for autoimmune diseases.
Researchers identified a special class of fatty molecules essential for activating immune cells, offering new opportunities for therapeutic interventions. The discovery sheds light on how recognition of these stimulatory fatty molecules by immune cells protects against infection, autoimmune diseases, and cancer.
Chronic psychological stress is associated with a loss of ability to regulate inflammatory response, promoting disease development. Inflammation plays a key role in various diseases like cardiovascular and autoimmune disorders.
A genetic mutation in the PLCG2 gene causes a rare immune disorder characterized by excessive and impaired immune function, leading to symptoms such as cold-induced hives, immune deficiency, and autoimmunity. The study identifies a unique genetic mechanism at the crux of allergy, immune defense, and self-tolerance.
Researchers have eliminated two possible causes of joint pain in women taking breast cancer medications: inflammatory arthritis and autoimmune disease. Despite finding no link between the medication and these conditions, doctors recommend continuing treatment to gain full benefits.
Transplantation specialists propose changes to liver organ distribution to prioritize patients with high MELD scores and reduce waitlist mortality. The new model aims to rapidly allocate organs to those most in need, ensuring timely delivery and reducing death rates.
Researchers have discovered that a specific type of T-cell can kill neurons, raising concerns about the potential effectiveness of an MS therapy. The study found that these protective T-cells, which are meant to regulate the immune system, can instead cause autoimmune diseases like MS.
Researchers at TU Delft are developing an objective, quantitative method to assess MRI scans for Crohn's disease activity. This new method aims to improve disease monitoring and reduce the need for colonoscopies, a stressful procedure.
Researchers at Georgetown University Medical Center found no conclusive evidence linking joint complaints to inflammatory arthritis or autoimmune disease in women taking aromatase inhibitors. However, they suggest encouraging women to continue taking the medication despite joint pain.
A team of researchers is studying the human gut microbiome to develop new interventions and treatments for food- and water-borne diseases. The study aims to understand how certain microbes protect against enteric diseases and identify potential therapeutic targets.
Two UNC School of Medicine faculty authored an editorial discussing the results of two clinical trials using Rituximab to treat small-vessel vasculitis, a rare autoimmune disease. The trials showed that Rituximab was effective in inducing remission compared to other treatments.
Researchers at Oregon State University discovered that the genetic regulator Ctip2 controls the formation of T cells, a type of white blood cell crucial for immune function. This finding may lead to new immune system-based therapies for diseases like HIV/AIDS and autoimmune disorders.
Researchers have discovered a gene linked to a newly recognized multisystem autoimmune disorder affecting Amish children, characterized by chronic diarrhea, enlarged organs, and developmental delays. The ITCH gene plays a crucial role in regulating the immune system, and identifying it may lead to effective treatment for these children.
A new study identifies autoantibodies targeting Trib2 protein in narcolepsy patients with cataplexy, supporting the theory that narcolepsy is an autoimmune disorder. Elevated levels of these antibodies were found in narcolepsy patients, furthering research on the underlying causes of the condition.
A new study finds that fibrocytes, a type of immune cell, are present at higher frequencies in patients with Graves' disease, leading to scarring and inflammation in the orbit. This discovery may lead to new treatments targeting scarring or fibrosis.
A study of 357 patients who underwent rhinoplasty using irradiated homologous costal cartilage found low complication rates, including 3.25% warping, infection, or resorption. Patient satisfaction was high at 94.2%, making this graft material a reliable alternative to autologous cartilage.
Researchers at NIEHS found an association between UV radiation and the frequency of dermatomyositis in women. Women with higher UV levels were more likely to develop this form of myositis, which weakens muscles and causes distinctive rashes.
A new mouse model reveals that innate immunity plays a key role in driving symptoms of auto-inflammatory diseases. The study shows that the innate immune system is responsible for the over-activation leading to inflammation and symptoms.
Research suggests that supplementing with vitamin D can exacerbate autoimmune diseases by deactivating the immune response and allowing bacteria to spread more easily. The form of vitamin D derived from food and supplements, 25-hydroxyvitamin D, is a secosteroid rather than a vitamin.